QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Clinical trial NCT07463573 · RECRUITING
Trial details
- NCT number
- NCT07463573
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-20
- Primary completion
- 2028-06-05
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.